Funding
Funding not disclosed
Founders
Product
Problem
Managing surgical wounds, burns, and ulcers presents challenges in maintaining optimal moisture balance and preventing microbial colonization, which can impede healing and lead to complications. Traditional wound dressings may not effectively address both antimicrobial protection and biocompatibility, potentially hindering tissue regeneration.
Solution
Imbed Biosciences develops advanced wound care products featuring a fully synthetic, antimicrobial, and biocompatible matrix designed to enhance healing outcomes. Their product lines, including Surgaflex™ for surgical wounds, PelashieldAM™ for burn wounds, and Microlyte® Matrix for chronic wounds, are formulated to provide a precise combination of key healing elements. The matrices conform to the wound bed, deliver non-toxic, broad-spectrum antimicrobial silver to prevent microbial colonization, and assist in maintaining optimal moisture balance. These products aim to improve outcomes in the management of acute, complex, and chronic wounds.
Target Audience
The primary target audience includes healthcare providers, such as surgeons, burn specialists, and wound care specialists, who treat patients with surgical wounds, burns, and ulcers.
Features
- Surgaflex™: An ultrathin, low-profile antimicrobial polymer matrix for acute and surgical wounds.
- PelashieldAM™: A hydrophilic, antimicrobial matrix specifically designed for burn wounds.
- Microlyte® Matrix: A synthetic skin substitute used in the treatment of chronic wounds.
- Fully synthetic and biocompatible matrix that naturally conforms to the underlying wound bed.
- Non-toxic and broad-spectrum antimicrobial silver to prevent and reduce microbial colonization.
- Products assist in maintaining optimal moisture balance in the healing environment.
- Registered with the U.S. FDA as a medical device manufacturer.
- Maintains an ISO 13485 certified Quality Management System.